CUSIP 702712100COMPASGQ3 2025
43 filings · latest Nov 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | New Leaf Venture Partners, L.L.C. | 87.4K | $702.0K |
| 2 | Cwm, LLC | 1 | $0 |
| 4 | Jul 9, 2025 | Orbimed Advisors LLC | 13D/A | 9.5% | — | SEC |
| 5 | Apr 25, 2025 | Orbimed Advisors LLC | 13D/A | 10.7% | — | SEC |
| 6 | Feb 14, 2025 | Lynx1 Capital Management LP | 13G/A | 15.0% | 9.26M | SEC |
| 7 | Dec 26, 2024 | Orbimed Advisors LLC | 13D/A | 12.0% | — | SEC |
| 8 | Nov 14, 2024 | Erste Asset Management Gmbh | 13G/A | 4.4% | 2.46M | SEC |
| 9 | Nov 14, 2024 | Erste Asset Management Gmbh | 13G | 5.4% | 2.96M | SEC |
| 10 | Nov 14, 2024 | Vestal Point Capital, LP | 13G | 9.9% | 6.10M | SEC |
See the full Schedule 13D/13G history for Passage Bio Inc.
Unlock full history